4D–Dynamic Contrast-Enhanced MRI for Preoperative Localization in Patients with Primary Hyperparathyroidism

References

1. 1.↵
   1. Ruda JM,
   2. Hollenbeak CS,
   3. Stack BC Jr..

   A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 2005;132:359–72 doi:10.1016/j.otohns.2004.10.005 pmid:15746845

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Heath H 3rd.,
   2. Hodgson SF,
   3. Kennedy MA

   . Primary hyperparathyroidism: incidence, morbidity, and potential economic impact in a community. N Engl J Med 1980;302:189–93 doi:10.1056/NEJM198001243020402 pmid:7350459

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Ghandur-Mnaymneh L,
   2. Kimura N

   . The parathyroid adenoma: a histopathologic definition with a study of 172 cases of primary hyperparathyroidism. Am J Pathol 1984;115:70–83 pmid:6711681

   PubMedWeb of Science
4. 4.↵
   1. Kazaure HS,
   2. Thomas S,
   3. Scheri RP, et al

   . The devil is in the details: assessing treatment and outcomes of 6,795 patients undergoing remedial parathyroidectomy in the Collaborative Endocrine Surgery Quality Improvement Program. Surgery 2019;165:242–49 doi:10.1016/j.surg.2018.03.026 pmid:30327186

   CrossRefPubMed
5. 5.↵
   1. Kunstman JW,
   2. Udelsman R

   . Superiority of minimally invasive parathyroidectomy. Adv Surg 2012;46:171–89 doi:10.1016/j.yasu.2012.04.004 pmid:22873039

   CrossRefPubMed
6. 6.↵
   1. Beland MD,
   2. Mayo-Smith WW,
   3. Grand DJ, et al

   . MDCT for localization of occult parathyroid adenomas in 26 patients with primary hyperparathyroidism. AJR Am J Roentgenol 2011;196:61–65 doi:10.2214/AJR.10.4459 pmid:21178047

   CrossRefPubMed
7. 7.↵
   1. Udelsman R,
   2. Lin Z,
   3. Donovan P

   . The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism. Ann Surg 2011;253:585–91 doi:10.1097/SLA.0b013e318208fed9 pmid:21183844

   CrossRefPubMed
8. 8.↵
   1. Harari A,
   2. Zarnegar R,
   3. Lee J, et al

   . Computed tomography can guide focused exploration in select patients with primary hyperparathyroidism and negative sestamibi scanning. Surgery 2008;144:970–76; discussion 976–79 doi:10.1016/j.surg.2008.08.029 pmid:19041005

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Smith N,
   2. Magnuson JS,
   3. Vidrine DM, et al

   . Minimally invasive parathyroidectomy: use of intraoperative parathyroid hormone assays after 2 preoperative localization studies. Arch Otolaryngol Head Neck Surg 2009;135:1108–11 doi:10.1001/archoto.2009.160 pmid:19917923

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Rodgers SE,
    2. Hunter GJ,
    3. Hamberg LM, et al

    . Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery 2006;140:932–40; discussion 940–41 doi:10.1016/j.surg.2006.07.028 pmid:17188140

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Hoang JK,
    2. Sung WK,
    3. Bahl M, et al

    . How to perform parathyroid 4D-CT: tips and traps for technique and interpretation. Radiology 2014;270:15–24 doi:10.1148/radiol.13122661 pmid:24354373

    CrossRefPubMed
12. 12.↵
    1. Day KM,
    2. Elsayed M,
    3. Beland MD, et al

    . The utility of 4-dimensional computed tomography for preoperative localization of primary hyperparathyroidism in patients not localized by sestamibi or ultrasonography. Surgery 2015;157:534–39 doi:10.1016/j.surg.2014.11.010 pmid:25660183

    CrossRefPubMed
13. 13.↵
    1. Mahajan A,
    2. Starker LF,
    3. Ghita M, et al

    . Parathyroid four-dimensional computed tomography: evaluation of radiation dose exposure during preoperative localization of parathyroid tumors in primary hyperparathyroidism. World J Surg 2012;36:1335–39 doi:10.1007/s00268-011-1365-3 pmid:22146947

    CrossRefPubMed
14. 14.↵
    1. Kelly HR,
    2. Hamberg LM,
    3. Hunter GJ

    . 4D-CT for preoperative localization of abnormal parathyroid glands in patients with hyperparathyroidism: accuracy and ability to stratify patients by unilateral versus bilateral disease in surgery-naive and re-exploration patients. AJNR Am J Neuroradiol 2014;35:176–81 doi:10.3174/ajnr.A3615 pmid:23868155

    Abstract/FREE Full Text
15. 15.↵
    1. Madorin CA,
    2. Owen R,
    3. Coakley B, et al

    . Comparison of radiation exposure and cost between dynamic computed tomography and sestamibi scintigraphy for preoperative localization of parathyroid lesions. JAMA Surg 2013;148:500–03 doi:10.1001/jamasurg.2013.57 pmid:23575888

    CrossRefPubMed
16. 16.↵
    1. Ron E,
    2. Lubin JH,
    3. Shore RE, et al

    . Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies—1995. Radiat Res 2012;178:AV43–60 doi:10.1667/rrav05.1 pmid:22870979

    CrossRefPubMed
17. 17.↵
    1. Kluijfhout WP,
    2. Pasternak JD,
    3. Beninato T, et al

    . Diagnostic performance of computed tomography for parathyroid adenoma localization; a systematic review and meta-analysis. Eur J Radiology 2017;88:117–28 doi:10.1016/j.ejrad.2017.01.004 pmid:28189196

    CrossRefPubMed
18. 18.
    1. Griffith B,
    2. Chaudhary H,
    3. Mahmood G, et al

    . Accuracy of 2-phase parathyroid CT for the preoperative localization of parathyroid adenomas in primary hyperparathyroidism. AJNR Am J Neuroradiol 2015;36:2373–79 doi:10.3174/ajnr.A4473 pmid:26359149

    Abstract/FREE Full Text
19. 19.↵
    1. Hunter GJ,
    2. Ginat DT,
    3. Kelly HR, et al

    . Discriminating parathyroid adenoma from local mimics by using inherent tissue attenuation and vascular information obtained with four-dimensional CT: formulation of a multinomial logistic regression model. Radiology 2014;270:168–75 doi:10.1148/radiol.13122851 pmid:24009349

    CrossRefPubMed
20. 20.↵
    1. Ramirez AG,
    2. Shada AL,
    3. Martin AN, et al

    . Clinical efficacy of 2-phase versus 4-phase computed tomography for localization in primary hyperparathyroidism. Surgery 2016;160:731–37 doi:10.1016/j.surg.2016.04.016 pmid:27302106

    CrossRefPubMed
21. 21.↵
    1. Nael K,
    2. Hur J,
    3. Bauer A, et al

    . Dynamic 4D MRI for characterization of parathyroid adenomas: multiparametric analysis. AJNR Am J Neuroradiol 2015;36:2147–52 doi:10.3174/ajnr.A4425 pmid:26359150

    Abstract/FREE Full Text
22. 22.↵
    1. Merchavy S,
    2. Luckman J,
    3. Guindy M, et al

    . 4D MRI for the localization of parathyroid adenoma: a novel method in evolution. Otolaryngol Head Neck Surg 2016;154:446–48 doi:10.1177/0194599815618199 pmid:26598499

    CrossRefPubMed
23. 23.↵
    1. Le Y,
    2. Kroeker R,
    3. Kipfer HD, et al

    . Development and evaluation of TWIST Dixon for dynamic contrast-enhanced (DCE) MRI with improved acquisition efficiency and fat suppression. J Magn Reson Imaging 2012;36:483–91 doi:10.1002/jmri.23663 pmid:22544731

    CrossRefPubMed
24. 24.↵
    1. Breuer FA,
    2. Blaimer M,
    3. Heidemann RM, et al

    . Controlled aliasing in parallel imaging results in higher acceleration (CAIPIRINHA) for multi-slice imaging. Magn Reson Med 2005;53:684–91 doi:10.1002/mrm.20401 pmid:15723404

    CrossRefPubMed
25. 25.↵
    1. Starker LF,
    2. Mahajan A,
    3. Bjorklund P, et al

    . 4D parathyroid CT as the initial localization study for patients with de novo primary hyperparathyroidism. Ann Surg Oncol 2011;18:1723–28 doi:10.1245/s10434-010-1507-0 pmid:21184187

    CrossRefPubMed
26. 26.↵
    1. Lundstroem AK,
    2. Trolle W,
    3. Soerensen CH, et al

    . Preoperative localization of hyperfunctioning parathyroid glands with 4D-CT. Eur Arch Otorhinolaryngol 2016;273:1253–59 doi:10.1007/s00405-015-3509-9 pmid:25773486

    CrossRefPubMed
27. 27.↵
    1. Chazen JL,
    2. Gupta A,
    3. Dunning A, et al

    . Diagnostic accuracy of 4D-CT for parathyroid adenomas and hyperplasia. AJNR Am J Neuroradiol 2012;33:429–33 doi:10.3174/ajnr.A2805 pmid:22135127

    Abstract/FREE Full Text
28. 28.↵
    1. Bahl M,
    2. Sepahdari AR,
    3. Sosa JA, et al

    . Parathyroid adenomas and hyperplasia on four-dimensional CT scans: three patterns of enhancement relative to the thyroid gland justify a three-phase protocol. Radiology 2015;277:454–62 doi:10.1148/radiol.2015142393 pmid:26024308

    CrossRefPubMed
29. 29.↵
    1. Stevens SK,
    2. Chang JM,
    3. Clark OH, et al

    . Detection of abnormal parathyroid glands in postoperative patients with recurrent hyperparathyroidism: sensitivity of MR imaging. AJR Am J Roentgenol 1993;160:607–12 doi:10.2214/ajr.160.3.8430565 pmid:8430565

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Grayev AM,
    2. Gentry LR,
    3. Hartman MJ, et al

    . Presurgical localization of parathyroid adenomas with magnetic resonance imaging at 3.0 T: an adjunct method to supplement traditional imaging. Ann Surg Oncol 2012;19:981–89 doi:10.1245/s10434-011-2046-z pmid:21879264

    CrossRefPubMed
31. 31.↵
    1. McDermott VG,
    2. Fernandez RJ,
    3. Meakem TJ, et al

    . Preoperative MR imaging in hyperparathyroidism: results and factors affecting parathyroid detection. AJR Am J Roentgenol 1996;166:705–10 doi:10.2214/ajr.166.3.8623655 pmid:8623655

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Lopez Hanninen E,
    2. Vogl TJ,
    3. Steinmuller T, et al

    . Preoperative contrast-enhanced MRI of the parathyroid glands in hyperparathyroidism. Invest Radiol 2000;35:426–30 doi:10.1097/00004424-200007000-00005 pmid:10901104

    CrossRefPubMed
33. 33.↵
    1. Ruf J,
    2. Lopez Hanninen E,
    3. Steinmuller T, et al

    . Preoperative localization of parathyroid glands: use of MRI, scintigraphy, and image fusion. Nuklearmedizin 2004;43:85–90 doi:10.1055/s-0038-1625596 pmid:15201949

    CrossRefPubMed
34. 34.↵
    1. Krubsack AJ,
    2. Wilson SD,
    3. Lawson TL, et al

    . Prospective comparison of radionuclide, computed tomographic, sonographic, and magnetic resonance localization of parathyroid tumors. Surgery 1989;106:639–44; discussion 644–46 pmid:2678555

    PubMed
35. 35.↵
    1. Seelos KC,
    2. DeMarco R,
    3. Clark OH, et al

    . Persistent and recurrent hyperparathyroidism: assessment with gadopentetate dimeglumine-enhanced MR imaging. Radiology 1990;177:373–78 doi:10.1148/radiology.177.2.2217771 pmid:2217771

    CrossRefPubMed
36. 36.↵
    1. Ozturk M,
    2. Polat AV,
    3. Celenk C, et al

    . The diagnostic value of 4D MRI at 3T for the localization of parathyroid adenomas. Eur J Radiol 2019;112:207–13 doi:10.1016/j.ejrad.2019.01.022 pmid:30777212

    CrossRefPubMed
37. 37.↵
    1. Kluijfhout WP,
    2. Venkatesh S,
    3. Beninato T, et al

    . Performance of magnetic resonance imaging in the evaluation of first-time and reoperative primary hyperparathyroidism. Surgery 2016;160:747–54 doi:10.1016/j.surg.2016.05.003 pmid:27318765

    CrossRefPubMed
38. 38.↵
    1. Turski PA,
    2. Korosec FR,
    3. Carroll TJ, et al

    . Contrast-enhanced magnetic resonance angiography of the carotid bifurcation using the time-resolved imaging of contrast kinetics (TRICKS) technique. Top Magn Reson Imaging 2001;12:175–81 doi:10.1097/00002142-200106000-00004 pmid:11432576

    CrossRefPubMed
39. 39.↵
    1. Aschenbach R,
    2. Tuda S,
    3. Lamster E, et al

    . Dynamic magnetic resonance angiography for localization of hyperfunctioning parathyroid glands in the reoperative neck. Eur J Radiol 2012;81:3371–77 doi:10.1016/j.ejrad.2012.05.023 pmid:22695787

    CrossRefPubMed
40. 40.↵
    1. Sho S,
    2. Yuen AD,
    3. Yeh MW, et al

    . Factors associated with discordance between preoperative parathyroid 4-dimensional computed tomographic scans and intraoperative findings during parathyroidectomy. JAMA Surg 2017;152:1141–47 doi:10.1001/jamasurg.2017.2649 pmid:28793141

    CrossRefPubMed
41. 41.↵
    1. Shen Y,
    2. Goerner FL,
    3. Snyder C, et al

    . T1 relaxivities of gadolinium-based magnetic resonance contrast agents in human whole blood at 1.5, 3, and 7 T. Invest Radiol 2015;50:330–38 doi:10.1097/RLI.0000000000000132 pmid:25658049

    CrossRefPubMed
42. 42.↵
    1. Schneider G,
    2. Pasowicz M,
    3. Vymazal J, et al

    . Gadobenate dimeglumine and gadofosveset trisodium for MR angiography of the renal arteries: multicenter intraindividual crossover comparison. AJR Am J Roentgenol 2010;195:476–85 doi:10.2214/AJR.09.3868 pmid:20651208

    CrossRefPubMed
43. 43.↵
    1. Gaddikeri S,
    2. Mossa-Basha M,
    3. Andre JB, et al

    . Optimal fat suppression in head and neck MRI: comparison of multipoint Dixon with 2 different fat-suppression techniques, spectral presaturation and inversion recovery, and STIR. AJNR Am J Neuroradiol 2018;39:362–68 doi:10.3174/ajnr.A5483 pmid:29242364

    Abstract/FREE Full Text
44. 44.↵
    1. Iglesias ML,
    2. Schmidt A,
    3. Ghuzlan AA, et al

    . Radiation exposure and thyroid cancer: a review. Arch Endocrinol Metab 2017;61:180–87 doi:10.1590/2359-3997000000257 pmid:28225863

    CrossRefPubMed
45. 45.↵
    1. Sinnott B,
    2. Ron E,
    3. Schneider AB

    . Exposing the thyroid to radiation: a review of its current extent, risks, and implications. Endocr Rev 2010;31:756–73 doi:10.1210/er.2010-0003 pmid:20650861

    CrossRefPubMedWeb of Science
46. 46.↵
    1. Mortenson MM,
    2. Evans DB,
    3. Lee JE, et al

    . Parathyroid exploration in the reoperative neck: improved preoperative localization with 4D-computed tomography. J Am Coll Surg 2008;206:888–95; discussion 895–96 doi:10.1016/j.jamcollsurg.2007.12.044 pmid:18471717

    CrossRefPubMedWeb of Science
47. 47.↵
    1. Linda DD,
    2. Ng B,
    3. Rebello R, et al

    . The utility of multidetector computed tomography for detection of parathyroid disease in the setting of primary hyperparathyroidism. Can Assoc Radiol J 2012;63:100–08 doi:10.1016/j.carj.2010.12.002 pmid:21955750

    CrossRefPubMed
48. 48.↵
    1. Gafton AR,
    2. Glastonbury CM,
    3. Eastwood JD, et al

    . Parathyroid lesions: characterization with dual-phase arterial and venous enhanced CT of the neck. AJNR Am J Neuroradiol 2012;33:949–52 doi:10.3174/ajnr.A2885 pmid:22241395

    Abstract/FREE Full Text
49. 49.↵
    1. Noureldine SI,
    2. Aygun N,
    3. Walden MJ, et al

    . Multiphase computed tomography for localization of parathyroid disease in patients with primary hyperparathyroidism: how many phases do we really need? Surgery 2014;156:1300–06; discussion 13006–07 doi:10.1016/j.surg.2014.08.002 pmid:25262222

    CrossRefPubMed